S'abonner

Prioritising locations for radiotherapy equipment in Brazil: a cross-sectional, population-based study and development of a LINAC shortage index - 29/03/22

Doi : 10.1016/S1470-2045(22)00123-1 
Gustavo A Viani, ProfPhD a, Andre G Gouveia, MD c, Vanessa F Bratti, MPH d, Juliana F Pavoni, ProfPhD b, Richard Sullivan, ProfPhD h, Wilma M Hopman, MA d, Christopher M Booth, MD e, f, Ajay Aggarwal, MSc i, j, Timothy P Hanna, PhD e, f, Fabio Y Moraes, PhD f, g,
a Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil 
b Department of Physics, Faculty of Philosophy, Sciences and Letters, Ribeirão Preto, University of São Paulo, São Paulo, Brazil 
c Radiation Oncology Department, Americas Centro de Oncologia Integrado, Rio de Janeiro, Brazil 
d Department of Public Health Sciences, Queen’s University, Kingston, ON, Canada 
e Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen’s University, Kingston, ON, Canada 
f Department of Oncology, Queen’s University, Kingston, ON, Canada 
g Division of Radiation Oncology, Kingston General Hospital, Kingston Health Sciences Centre, Kingston, ON, Canada 
h Institute of Cancer Policy, Global Oncology Group, King’s College London, London, UK 
i Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK 
j Department of Clinical Oncology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK 

* Correspondence to: Dr Fabio Ynoe Moraes, Division of Radiation Oncology, Kingston General Hospital, Kingston Health Sciences Centre, Queen’s University Kingston, K7L 2V7, ON, Canada Division of Radiation Oncology Kingston General Hospital Kingston Health Sciences Centre Queen’s University Kingston ON K7L 2V7 Canada

Summary

Background

Similarly to several other upper-middle-income countries, there is a major shortfall in radiotherapy services for the treatment of cancer in Brazil. In this study, we developed the linear accelerator (LINAC) shortage index to assess the LINAC shortage and support the prioritisation of new LINAC distribution in Brazil.

Methods

This cross-sectional, population-based study used data from the National Cancer Institute 2020 Cancer estimates, the Ministry of Health 2019 radiotherapy census, the Minister of Health radiotherapy expansion programme progress reports, and the Fundação Oncocentro de São Paulo public database of the Cancer Hospital Registry of the State of São Paulo to calculate the LINAC shortage index. Data collected were number of new cancer cases in Brazil, number of LINACs per region and state, number of cancer cases treated with radiotherapy, patient state of residence, and radiotherapy treatment centre and location. National, regional, and state-level data were collected for analysis. LINAC numbers, cancer incidence, geographical distribution, and radiotherapy needs were estimated. A LINAC shortage index was calculated as a relative measure of LINAC demand compared with supply based on number of new cancer cases, number of patients requiring radiotherapy, and the number of LINCAS in the region or state. We then built a prioritisation framework using the LINAC shortage index, cancer incidence, and geographical factors. Finally, using patient-level public cancer registry data from the Fundação Oncocentro de São Paulo and Google maps, we estimated the geospatial distance travelled by patients with cancer from their state of residence to radiotherapy treatment in São Paulo from 2005–14. Non-parametric statistics were used for analysis.

Findings

Data were collected between Feb 2 and Dec 31, 2021. In 2020, there were 625 370 new cancer cases in Brazil and 252 LINAC machines. The number of LINACs was inadequate in all Brazilian regions, with a national LINAC shortage index of 221 (ie, 121% less than the required radiotherapy capacity). The LINAC shortage index was higher in the midwest (326), north (313), and northeast (237) regions, than the southeast (210) and south (192) regions. Four states (Tocantins, Acre, Amapá, and Roraima) in the north region were ranked first on the prioritisation rank due to no availability of LINACs. There was an association between LINAC shortage index and the number of patients who travelled to receive radiotherapy (p<0·0001). Patients living in the midwest (793 km), north (2835 km), and northeast (2415 km) regions travelled significantly longer average distances to receive radiotherapy treatment in São Paulo than patients living in the southeast or south regions (p=0·032). The reduced number of LINACs in these regions was associated with longer distance travelled (p=0·032).

Interpretation

There is substantial discordance between distribution of cancer cases and LINAC availability in Brazil. We developed a tool using the LINACs shortage index to help prioritise the development of radiotherapy infrastructure across Brazil; this approach might also be useful in other health systems.

Funding

None.

Le texte complet de cet article est disponible en PDF.

Plan


© 2022  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 23 - N° 4

P. 531-539 - avril 2022 Retour au numéro
Article précédent Article précédent
  • Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
  • Darren Jun Hao Tan, Cheng Han Ng, Snow Yunni Lin, Xin Hui Pan, Phoebe Tay, Wen Hui Lim, Margaret Teng, Nicholas Syn, Grace Lim, Jie Ning Yong, Jingxuan Quek, Jieling Xiao, Yock Young Dan, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark D Muthiah, Rohit Loomba, Daniel Q Huang
| Article suivant Article suivant
  • Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
  • Hedy L Kindler, Silvia Novello, Alessandra Bearz, Giovanni L Ceresoli, Joachim G J V Aerts, James Spicer, Paul Taylor, Kristiaan Nackaerts, Alastair Greystoke, Ross Jennens, Luana Calabrò, Jacobus A Burgers, Armando Santoro, Susana Cedrés, Piotr Serwatowski, Santiago Ponce, Jan P Van Meerbeeck, Anna K Nowak, George Blumenschein, Jonathan M Siegel, Linda Kasten, Karl Köchert, Annette O Walter, Barrett H Childs, Cem Elbi, Raffit Hassan, Dean A Fennell

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.